✦ LIBER ✦

Docetaxel plus carboplatin shows promise in the first-line treatment of ovarian cancer,

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin-docetaxel (Taxotere®) in first

✍ V. Dieras; J.M. Ferrero; R. Kheder; B. Weber; P. Winckel; A. Lortho-lary; F. May 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Weekly epirubicin plus docetaxel as firs

✍ Gamucci, T; D'Ottavio, A M; Magnolfi, E; Barduagni, M; Vaccaro, A; Sperduti, I; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

Docetaxel (D) and carboplatin with Auc-7

✍ Mehrdad Salimi; Manuchehr Davaee 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 150 KB

SCOTROC 2B: feasibility of carboplatin f

✍ Clamp, A R; Mäenpää, J; Cruickshank, D; Ledermann, J; Wilkinson, P M; Welch, R; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

A dose finding study of docetaxel/carbop

✍ R. Atkinson; P.A. Vasey; R. Coleman; M. Crawford; M. Cruickshank; P. Eggleton; D 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 157 KB

First-line treatment of ovarian cancer F

✍ G. B. Kristensen; I. Vergote; G. Stuart; J. M. Del Campo; J. Kaern; A. B. Lopez; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB